Evidence map›Paper›PMID 36072675›Full record

ArticleFrontiers in genetics2022

Clinical Utility of Medical Exome Sequencing: Expanded Carrier Screening for Patients Seeking Assisted Reproductive Technology in China.

Keya Tong, Wenbin He, Yao He, Xiurong Li, Liang Hu, Hao Hu, Guangxiu Lu, Ge Lin, Chang Dong, Victor Wei Zhang and 2 more

Abstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Keya TongCenter for Reproductive Medicine, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
Wenbin HeNational Engineering and Research Center of Human Stem Cells, Changsha, China.
Yao HeCenter for Reproductive Medicine, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
Xiurong LiNational Engineering and Research Center of Human Stem Cells, Changsha, China.
Liang HuNational Engineering and Research Center of Human Stem Cells, Changsha, China.
Hao HuNational Engineering and Research Center of Human Stem Cells, Changsha, China.
Guangxiu LuNational Engineering and Research Center of Human Stem Cells, Changsha, China.
Ge LinNational Engineering and Research Center of Human Stem Cells, Changsha, China.
Chang DongAmCare Genomics Lab, Guangzhou, China.
Victor Wei ZhangAmCare Genomics Lab, Guangzhou, China.
Juan DuNational Engineering and Research Center of Human Stem Cells, Changsha, China.
Dongyun LiuCenter for Reproductive Medicine, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

assisted reproductive technologyclinical utilityexpanded carrier screeningHan Chinese ethnicitypreimplantation genetic testing

Identifiers

PMID36072675
PMCPMC9441495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.